Ohara M et al. |
Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy. |
2018 |
Intern. Med. |
pmid:29269644
|
Nakahara T et al. |
Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis. |
2018 |
Pediatr Allergy Immunol |
pmid:29205511
|
Ixtlapale-Carmona X et al. |
Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies. |
2018 |
Transpl. Immunol. |
pmid:28974434
|
Felipe C et al. |
Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients. |
2018 |
Ther Drug Monit |
pmid:29271815
|
Kimura Y et al. |
Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. |
2018 |
Arch. Toxicol. |
pmid:29594315
|
Sablik KA et al. |
Tacrolimus intra-patient variability is not associated with chronic active antibody mediated rejection. |
2018 |
PLoS ONE |
pmid:29746495
|
Tang JT et al. |
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. |
2018 |
Ann. Transplant. |
pmid:29735966
|
Riva N et al. |
Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation. |
2018 |
Ther Drug Monit |
pmid:29621122
|
Liu J et al. |
Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients. |
2018 |
Int. Immunopharmacol. |
pmid:29454235
|
Choi CB et al. |
Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. |
2018 |
Lupus |
pmid:29448881
|